News

July 27, 2017 - PreciThera Inc. Completes $36 Million Series A Financing: Funding to Develop Novel Biologics Targeting Orphan Bone Diseases into Clinical Trials Read More

June 15, 2017 - ViaCyte Presents at the ISSCR 2017 Annual Meeting in Boston Read More

June 1, 2017 - Can DalCor Pharma Succeed Where Others Have Failed? Read More

May 27, 2017 - Sotera® Wireless To Spotlight Surveillance Monitoring For Patient Safety At AAMI 2016 Read More

May 24, 2017 - CalciMedica Receives Fast-Track Designation For CM4620, A Novel CRAC Channel Inhibitor To Treat Acute Pancreatitis Read More

May 22, 2017 - ViaCyte Receives IND Allowance from FDA and Clearance from Health Canada to Commence International Clinical Trial of PEC-Direct Cell Therapy for High-Risk Type 1 Diabetes Read More

May 22, 2017 - JDRF and ViaCyte Announce Support for Development of PEC-Direct Cell Replacement Therapy for Type 1 Diabetes Read More

May 22, 2017 - ViaCyte Announces $10 Million in Financing Read More

May 10, 2017 - Emerillon Capital and Sanderling Ventures Join Forces Backing a New Precision Medicine Company Based in Montreal, Canada Read More

May 10, 2017 - Emerillon Capital et Sanderling Ventures joignent leurs forces afin de soutenir une nouvelle compagnie montréalaise en médecine de précision Read More